Loading...

About ADDAX

About ADDAX

ADDAX
Acid Deprived DiAldehyde FiXative

REPLACE THE USE OF FORMALIN AS A FIXATIVE SOLUTION

ADDAX Biosciences is an academic spin-off of the University of Turin, born after long time research activity of its founders on the fixation of pathological tissues. Our company goal is to replace the use of Formalin (a cancerogenic and toxic solution of Formaldehyde) as a fixative solution, while preserving optimal tissue fixation to guarantee correct diagnosis and therapy.

MORE INFORMATIONS

Write us to learn more about GAF.

THE HIGHEST STANDARD
OF ACCURACY AND RELIABILITY

We believe it is necessary to guarantee the highest standard of accuracy and reliability of the examinations carried out on biological samples, in order to preserve the health of the patients. At the same time, we also deem necessary to safeguard the health of the operators.

OUR TEAM

CEO & Founder

Giovanni Bussolati

Emeritus Professor of Pathology
Member of the Italian Lincei Academy of Science

R&D & Founder

Benedetta Bussolati

Associate Professor of Nephrology at the University of Turin

Linkedin

Legal, Commercial & Founder

Nicolò Bussolati

Attorney-at-Law
LLM – PhD

Linkedin

Collaborator

Giorgia Pansa

Lawyer

Linkedin

Investor

Michela Gastaldi

Chemical Engineer

Linkedin

Collaborator

Jasna Metovic

Medical Doctor and PhD student in Biomedical Sciences and Oncology

Linkedin

Collaborator

Paolo De Tillo

Biomedical Laboratory Technician

Linkedin

Collaborator

Francesca Veneziani

Biomedical Laboratory Technician

Collaborator

Federica Nascè

Marketing Manager Intern at Amazon

Linkedin

ADVISORY BOARD

Investor

Fabio Bellio

Purchasing & Supply Chain Manager at Ahlstrom Munksjo Italia

Financial Advisor

Sergio Traversa

PharmD, MBA, CEO of Relmada Therapeutics Inc.

Financial Advisor

Enrico Sorisio

Chartered accountant, business and tax consultant

Scientific Advisor

Anna Sapino

Professor of Pathology
Scientific Director, IRCC Candiolo Institute of Oncology

Scientific Advisor

Manfred Dietel

Professor of Pathology
Director of Institute of Pathology, University Hospital Charitè, Berlin

Scientific Advisor

Giorgio Stanta

Professor of Pathology at the University of Trieste

OUR COLLABORATIONS

Collaboration with A.O.U. Città della Salute e della Scienza in Turin, for the “Glyoxal in Endoscopy” project.

Collaboration with the Zooprophylactic Institute in Turin for GAF’s use in the veterinary sector, especially concerning neurological pathology.

Collaboration with the Polytechnic of Turin and the University of Turin for use of acid-free glyoxal as a fixative for valve and vascular prostheses.

Our company has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No 8157692.